" class="no-js "lang="en-US"> Cardinal Health & Signify Health to Offer In-Home Therapy
Friday, April 12, 2024

Cardinal Health’s Outcomes™ Collaborates with Signify Health to Offer In-Home Medication Therapy Management

Cardinal Health today announced its collaboration with Signify Health to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home.

Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health’s mobile network of 11,000+ credentialed clinicians with Outcomes’ industry-leading OutcomesOne™ clinical care platform and omnichannel network of pharmacies and payers, this collaboration will help to address medication management challenges for health plan members by offering coordinated care from Signify Health clinicians who are also performing evaluations of those members in the home. Using the insights gathered during in-home evaluations, Signify Health is able to use the OutcomesOne™ platform to identify and resolve the medication therapy management needs of members.

“At Outcomes, we’re working to revolutionize the healthcare journey by offering a more integrated experience that connects all sites of care,” said Brent Stutz, senior vice president and general manager of Outcomes™. “As more patients recover and manage their chronic illnesses from home, this collaboration with Signify Health will help drive more powerful connections across transitions of care, enabling pharmacies and payers to reach patients who are often most in need of additional support.”

The collaboration will initially focus on addressing interventions recommended for Medicare Advantage members of joint clients and may expand into additional services, such as population health programs, and additional clinical interventions.

“From our experience conducting medication reviews in thousands of homes each day, we understand the importance of making medication management more convenient, accessible and connected to daily life,” said David Pierre, chief operating officer, Signify Health. “We look forward to joining forces with Outcomes to bring this vital service to improve medication safety and adherence and drive more value for the people we are privileged to serve.”

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more